Global Cardiovascular Health
Global Health, Public Health, Cardiometabolic Disease
Research aim
To study cardiovascular risk factors and health outcomes; and develop, implement and scale-up cost-efficient approaches for primary and secondary prevention of cardiovascular disease to promote equity in cardiovascular health globally
About us
Global Cardiovascular Health undertakes research on cardiovascular risk (CV) factors and disease outcomes and clinical trials to test the effectiveness and impact of evidence-based interventions on CV health in partnership with academic and health care organisations globally.
Clinical guidelines recommend control of modifiable risk factors to reduce recurrence of CV events and mortality. The SUrvey of Risk Factors (SURF) study assesses CV factor recording and management globally to improve standard of care in daily practice and health outcomes.
The SCUBY study assesses the impact of scaling-up an integrated chronic care package on hypertension and diabetes outcomes in Asia and Europe. In the iHEART-South Africa study innovations for hypertension management are tested to expand the scope of HIV care in a sustainable, scalable, and impactful way.
The impact of urbanization-related environment, societal and biological changes on the development of CVD is increasingly recognized. Our research shows high prevalence of cardiometabolic disease in urbanized settings globally and the importance of social determinants for the prevention and management of life-style related CV risk (factors).
Pregnancy cohorts in Asia and Africa assess the effects of environmental exposures on the long-term health of mother and child. The SPOT-Studies in Ghana focus on prediction and implementation of optimal clinical management of hypertensive disorders of pregnancy.